HIF-1α Dependent Wound Healing Angiogenesis In Vivo Can Be Controlled by Site-Specific Lentiviral Magnetic Targeting of SHP-2
Open Access
- 1 July 2017
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 25 (7), 1616-1627
- https://doi.org/10.1016/j.ymthe.2017.04.007
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation (DFG
- Dr. Kleist-Stiftung
This publication has 35 references indexed in Scilit:
- Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodellingCardiovascular Research, 2010
- Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic miceProceedings of the National Academy of Sciences of the United States of America, 2009
- Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularizationProceedings of the National Academy of Sciences of the United States of America, 2009
- Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2009
- Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growthProceedings of the National Academy of Sciences of the United States of America, 2008
- Stabilization of HIF-1α is critical to improve wound healing in diabetic miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Angiogenic and antiangiogenic gene therapyGene Therapy, 2005
- The Tyrosine Phosphatase, SHP-1, Is a Negative Regulator of Endothelial Superoxide FormationJournal of the American College of Cardiology, 2005
- Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functionsExperimental & Molecular Medicine, 2004
- Role of SHP-2 in Fibroblast Growth Factor Receptor-Mediated Suppression of Myogenesis in C2C12 MyoblastsMolecular and Cellular Biology, 2002